Search Results - "Mensah, Samuel D"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy

    Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy by Dugbartey, George J., Alornyo, Karl K., N'guessan, Benoit B., Atule, Stephen, Mensah, Samuel D., Adjei, Samuel

    Published in Biomedicine & pharmacotherapy (01-05-2022)
    “…Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Current pharmacological interventions only retard DN progression. Alpha-lipoic acid…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway

    Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway by Dugbartey, George J, Wonje, Quinsker L, Alornyo, Karl K, Robertson, Louis, Adams, Ismaila, Boima, Vincent, Mensah, Samuel D

    Published in Frontiers in pharmacology (21-03-2022)
    “…Diabetic cardiomyopathy (DCM) is a major long-term complication of diabetes mellitus, accounting for over 20% of annual mortality rate of diabetic patients…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: